NIH adds another antibody to recommended treatments, studies look at early cases, racial disparities
Recent COVID-19 news includes a new NIH recommendation and studies of the earliest U.S. cases, an experimental inpatient drug, and potential causes of racial disparities in outcomes.
The College's statement stresses that physicians have a responsibility to advocate for the health and well-being of patients and communities locally and globally and calls for a coordinated global vaccination effort to be ethical as well as practical.
The Kidney Disease: Improving Global Outcomes Work Group recommends targeting a standardized systolic blood pressure less than 120 mm Hg in patients with chronic kidney disease (CKD) who are not receiving dialysis, among other guidance.
An industry-funded trial found that migraine pain resolved sooner with eptinezumab than placebo, while a meta-analysis found that several established and newer therapies for the acute treatment of migraine were associated with reductions in short-term pain.
ACP members can view the latest CME/MOC activities on the homepage or by searching the entire library by subject, learning format, or product. Most activities in the Online Learning Center are free to ACP members.